|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
|
Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology |
Children’s Hospital of Philadelphia |
Tap Cancer Out |
|
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University |
Tap Cancer Out |
|
Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor |
Ann & Robert H. Lurie Children’s Hospital of Chicago |
Tap Cancer Out, Emily’s Smiles Foundation |
|
Molecular Landscape for Targeted Therapy in Retinoblastoma |
University of Miami |
Tap Cancer Out |
|
Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma |
Stanford University |
Tap Cancer Out |
|
RNA Methylation in Metabolically Disrupted Pediatric Cancers |
University of Texas Health Science Center at San Antonio |
Flashes of Hope, Tap Cancer Out, Northwestern Mutual Foundation |
|
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma |
Nationwide Children’s Hospital |
Flashes of Hope, Tap Cancer Out |
|
The Role of Pyruvate Dehydrogenase in Leukemia |
University of Texas Southwestern Medical Center at Dallas |
Tap Cancer Out |